Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study (Preprint)
Authors:
- Sam PepperSPSam Pepper
- Isuru RatnayakeIRIsuru Ratnayake
- Mohammod Mahmudur RahmanMRMohammod Mahmudur Rahman
- Robiul Islam TalukderRTRobiul Islam Talukder
- Saiful Islam SaifSSSaiful Islam Saif
- Olivia RippeeOROlivia Rippee
- Ananda JayawardhanaAJAnanda Jayawardhana
- Tara LinTLTara Lin
- Natalie StreeterNSNatalie Streeter
- Byron GajewskiBGByron Gajewski
- Jo WickJWJo Wick
- Matthew S MayoMMMatthew S Mayo
Preprint
- 24 August 2025
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Clinical trial accrual monitoring is a critical component of trial operations, influencing feasibility, timeliness, and scientific validity. Despite its importance, many National Cancer Institute–designated cancer centers continue to rely on static spreadsheets or manually generated reports that provide delayed and incomplete insight for study teams. These limitations hinder timely identification of recruitment challenges, reduce transparency across stakeholders, and constrain proactive operational decision‑making. Scalable, institution‑wide systems that support near–real‑time accrual oversight remain uncommon in academic settings. OBJECTIVE This study aimed to design, implement, and operationalize a near–real‑time clinical trial accrual dashboard within a National Cancer Institute–designated cancer center, and to evaluate its use, adoption, and early operational impact on accrual monitoring workflows. METHODS We developed an enterprise accrual dashboard integrating daily extracts from the institutional clinical trial management system with automated data quality validation and time series accrual forecasting. The system supported multiple stakeholder roles through role‑based access and was deployed within existing governance and oversight workflows. Implementation and evaluation were guided by the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework and the Guidelines and Checklist for the Reporting on Digital Health Implementations framework, with system logs used to assess reach and adoption, and qualitative operational feedback used to characterize use in practice. RESULTS From May 2022 to May 2025, the dashboard was used institution wide for monitoring therapeutic and nontherapeutic trials, logging 1605 unique user sessions across investigators, coordinators, data managers, and leaders. Automated daily validation enabled earlier detection and correction of missing or invalid accrual data, improving the reliability of institutional reporting over time. The dashboard replaced manual monthly reports with continuous monitoring and was incorporated into routine operational and leadership reviews, enabling earlier identification of lagging studies and more timely discussions regarding resource allocation and recruitment strategies. Accrual forecasting models demonstrated stable in sample and out of sample performance and were used to support anticipatory planning rather than prescriptive decision making. Initial increases in data correction workload and user resistance decreased as workflows matured and data transparency became normalized. CONCLUSIONS Implementation of a near–real‑time accrual dashboard within an academic cancer center is feasible and sustainable and can meaningfully improve accrual oversight by strengthening data quality, transparency, and integration into routine workflows. The primary value of such systems lies not only in visualization or analytics but in their ability to shift accrual monitoring from retrospective reporting to proactive, institution‑wide operational review. With appropriate governance and clinical trial management system infrastructure, similar dashboards are transferable to other research centers seeking to modernize trial oversight.Keywords
All Related Versions
- Published version: JMIR Medical Informatics, 14, e82920.
This publication has 23 references indexed in Scilit:
- Understanding of Clinical Trials Among Patients With Cancer and Their RelativesJAMA Network Open, 2025
- Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for EvidenceJAMA, 2024
- Analysis of Rates of Completion, Delays, and Participant Recruitment in Randomized Clinical Trials in SurgeryJAMA Network Open, 2023
- Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic reviewContemporary Clinical Trials Communications, 2021
- Increasing Diversity in Clinical Trials: Overcoming Critical BarriersCurrent Problems in Cardiology, 2019
- A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventableJournal of Clinical Epidemiology, 2016
- The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literatureEuropean Journal of Clinical Pharmacology, 2016
- Barriers to clinical trial recruitment in head and neck cancerOral Oncology, 2015
- Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trialContemporary Clinical Trials, 2012
- Participation in Cancer Clinical TrialsJAMA, 2004